Cyclerion Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cyclerion Therapeutics Inc CYCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 1.58% 1.93 12:00:51
Open Price Low Price High Price Close Price Prev Close
1.96 1.83 1.96 1.90
more quote information »

Recent News

Date Time Source Heading
11/11/202117:32GLOBECyclerion Therapeutics to Participate in Jefferies London..
11/09/202116:54SEEKCyclerion Therapeutics EPS beats by $0.09, misses on revenue
11/09/202116:02EDGARCurrent Report Filing (8-k)
11/09/202116:01GLOBECyclerion Therapeutics Reports Third Quarter 2021 Financial..
9/30/202109:02EDGARCurrent Report Filing (8-k)
9/22/202108:00GLOBECyclerion Announces Publication of Preclinical Data..
9/08/202108:00GLOBECyclerion Therapeutics to Participate in Two Upcoming..
8/27/202117:03EDGARAmended Quarterly Report (10-q/a)
8/23/202117:00GLOBECyclerion Therapeutics to Present at Annual Biomarkers for..
8/19/202116:52EDGARCurrent Report Filing (8-k)
7/30/202116:32EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/29/202117:14SEEKCyclerion Therapeutics reports Q2 results
7/29/202117:00EDGARQuarterly Report (10-q)
7/29/202117:00GLOBECyclerion Therapeutics Reports Second Quarter 2021 Financial..
7/29/202116:55EDGARCurrent Report Filing (8-k)
7/22/202122:20SEEKCyclerion gains after announcing upcoming presentation of..
7/22/202116:30GLOBECyclerion Therapeutics to Present Clinical Trial Design for..
7/08/202119:22PRNUSBeacon Biosignals and Cyclerion Therapeutics Announce..
7/08/202116:30GLOBECyclerion Therapeutics and Beacon Biosignals Announce..
6/28/202117:28EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202117:26EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202117:23EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202117:18EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202117:14EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202117:12EDGARStatement of Changes in Beneficial Ownership (4)
6/24/202106:05EDGARNotice of Effectiveness (effect)
6/23/202112:45EDGARSecurities Registration Statement (simplified Form) (s-3/a)
6/17/202116:56EDGARSmall Company Offering and Sale of Securities Without..
6/16/202116:49EDGARSecurities Registration Statement (simplified Form) (s-3)
6/07/202117:36EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202117:26EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202117:22EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/04/202116:38EDGARCurrent Report Filing (8-k)
6/04/202108:00GLOBECyclerion Therapeutics Announces $18 Million Private..
5/27/202116:30GLOBECyclerion Therapeutics Announces Publication of CY6463..
5/25/202107:00GLOBECyclerion Therapeutics to Participate in Jefferies Virtual..
5/19/202118:17EDGARInitial Statement of Beneficial Ownership (3)
5/14/202116:57EDGARStatement of Beneficial Ownership (sc 13d)
5/10/202108:45EDGARStatement of Changes in Beneficial Ownership (4)
5/04/202116:40EDGARCurrent Report Filing (8-k)
4/28/202107:01EDGARProxy Statement (definitive) (def 14a)
4/27/202109:23EDGARCurrent Report Filing (8-k)
4/27/202109:00GLOBECyclerion Therapeutics Hosted Webinar to Discuss Pipeline..
4/26/202108:59EDGARCurrent Report Filing (8-k)
4/26/202107:00GLOBECyclerion Therapeutics Appoints Errol De Souza, Ph.D., to..
4/21/202107:30GLOBECyclerion Therapeutics to Participate in the B. Riley..
4/20/202107:00GLOBECyclerion Therapeutics to Host Pipeline Update Webinar
3/24/202116:05PRNUSTransMedics Appoints Stephanie Lovell to Board of Directors
3/19/202106:05EDGARAmended Current Report Filing (8-k/a)
3/18/202117:11SEEKCyclerion Therapeutics chief medical officer leaves
See more news about this stock »
Your Recent History
Cyclerion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211202 17:16:16